Date: 2024/11/03 - 18:50
Semaglutide, the active ingredient in Ozempic and Wegovy, may also help lower the risk of developing Alzheimer’s disease in people living with type 2 diabetes.
Date: 2024/11/03 - 00:50
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive function by reducing inflammation.
A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect the heart. However, certain doses and delivery systems can lead to side effects affecting the gut.
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's disease, new evidence shows.